Evaluation of fresh and osmotic SB effect on in vitro human-relevant disease models
Duration months: 4-21
Objectives
1. Assess SB of disease-preventive properties (anti-cancer, anti-inflammatory, gut microbiota regulating) of SB.
2. Determine the metabolomic, epiproteomic and proteomic changes incurred by fresh and osmotic fractions of SB.
All objectives are related to R&I activities through secondments.
Partners involved
We are joining forces with esteemed partners. Each contributes specialized expertise and resources. Together, we are dedicated to achieving our objectives and driving positive change.
Deliverables
D2.1
month 15
Report on the assessment of anti-cancer and anti-inflammatory potency
D2.2
month 15
Report of the activity towards gut microbiota
D2.3
month 21
List of relevant metabolites and metabolic
pathways altered by SB administration in vitro
D2.4
month 21
List of histone post-translational modifications altered
by SB administration in vitro
D2.5
month 21
List of proteins altered by SB administration in vitro
Project Coordinator
REZOS BRANDS EUROPEAN R&D DEPARTMENT
Eugenia Karamouzi
Address
196 New National Road Patras-Athens 26553
Patras | Greece
Contact
Email: projects@rezosbrands.com
Phone Number: +302610423021
Copyright @ 2023 RIA4FOOD | Privacy Policy
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Executive Agency (REA). Neither the European Union nor the granting authority can be held responsible for them. Grant agreement No 101131479.